FDA Advisory Committees Reject Oxycodegol (NKTR-181) Application Michele B. Kaufman, PharmD, BCGP | February 19, 2020FDA advisory committees rejected the new drug application for oxycodegol, an opioid analgesic, due to a lack of data regarding it’s potential for abuse…
NKTR-181 Promising for Chronic Low Back Pain Michele B. Kaufman, PharmD, BCGP | April 21, 2017NKTR-181, a mu-opioid agonist analgesic, has proved safe and effective for treating chronic low back pain vs. placebo in a recent clinical trial…